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Outbreaks of acute flaccid myelitis in the US
Enteroviruses are implicated, particularly D68
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The World Health Organization has declared much of the world
free of polio, including the UK (1982) and the US (1979).
However, acute flaccid myelitis and paralysis due to vaccine
associated poliomyelitis are still evident in Papua New Guinea,1
and large outbreaks of acute flaccid myelitis due to non-polio
enteroviruses (often enterovirus A71) have occurred, particularly
in South East Asia.2
Outbreaks of acute flaccid myelitis are currently ongoing in the
US, where the Centers for Disease Control and Prevention
(CDC) recently described an outbreak of a polio-like disease in
children as “a mystery illness.”3 Symptoms include sudden onset
of paralysis in the arms or legs and grey matter lesions in the
spinal cord. By the end of November 2018, the condition had
been confirmed in 116 children from 31 US states,4 an increase
of 250% from 2017, when 33 confirmed cases were recorded.
This is a rare condition, with 404 confirmed cases across the
US since the CDC began investigating in 2014.4
US outbreaks of acute flaccid myelitis occur roughly every other
year,4 a pattern similar to that of enterovirus A71 outbreaks in
different settings.5 The median age of patients involved in a
recent US outbreak was 4 years, and 99% of children had
symptoms of a respiratory or gastrointestinal infection in the
four weeks before presenting with acute flaccid myelitis,
suggesting a viral association.6 In the CDC’s 2018 report clinical
specimens from 38 (54%) of the 71 patients were positive for
enterovirus or rhinovirus.6 As these two viruses (both
picornaviridae) are so similar, it is difficult to differentiate them
without gene sequencing. Of the 38 patients, 14 were positive
for enterovirus D68 and 11 for A71.6 Poliovirus was not detected
in any specimen.
The enterovirus family includes poliovirus, enterovirus A71
(which usually causes the common childhood illness hand, foot,
and mouth disease), enterovirus D68 (usually causes mild
respiratory symptoms), and rhinovirus (cause of the common
cold). Enteroviruses A71 and D687 8 have both been associated
with acute flaccid myelitis, but D68 is emerging as the leading
causal candidate.
Large outbreaks of enterovirus D68 infections occurred across
the US, Europe, and Asia in 2014,9 with 1153 people (mostly
children) affected in the US alone.10 At the same time, many
cases of acute flaccid myelitis were reported among US
children,8 some of whom had laboratory confirmed enterovirus
D68 infection.8 11 Limb weakness or disability can persist for
more than 18 months after infection among children with acute
flaccid myelitis associated with enterovirus D68.7 12
The CDC has not attributed the current outbreak of acute flaccid
myelitis to an enterovirus, because enterovirus was detected in
just 10% (2/21) of available cerebrospinal fluid specimens.4 6
However, enterovirus is not always found in cerebrospinal fluid,7
and other evidence suggests that the current outbreak is caused
by enterovirus D68.13
Firstly, enteroviruses typically cause outbreaks every two to
three years,5 14 15 and outbreaks of acute flaccid myelitis in the
US seem to follow a two year pattern.4 Many scientists believe
this regular cycling is due to the seroprevalance of enterovirus
antibodies waning in the population every two years, as new
children are born without immunity.15 Secondly, there is a
temporal association between previous outbreaks of enterovirus
D68 and acute flaccid myelitis,13 for example, in the US in 2014.8
Thirdly, enterovirus D68 infects human neurones—a recent
study shows that enterovirus D68 strains, including 2014 strains,
can enter and replicate in neuronal cells.16 Finally, mice infected
with enterovirus D68 develop limb paralysis, although the virus
is not always detected in cerebrospinal fluid.17
Recognition is key to understanding the patterns of this disease,
along with fast, accurate diagnostic strategies that include local
or point-of-care testing. Individual responses to viral infection
vary, and symptoms will differ depending on host factors (such
as pre-existing conditions, immunosuppression, genetic factors),
and viral factors (subtype, genetic virulence).
Confirming the diagnosis can be difficult, but confirmation
should not delay use of treatments such as intravenous
immunoglobulin. Commercial preparations contain high levels
of neutralising antibodies against enterovirus D68,18 but
randomised clinical trials have not been done to evaluate their
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effectiveness. In one case series from Scotland, patients with
D68 associated acute flaccid myelitis showed varying levels of
recovery after treatment with intravenous immunoglobulin.12
Immunoglobulin may also benefit children with enterovirus
A71 infection, particularly those with more severe symptoms,
including encephalitis and encephalomyelitis.19
Collection of these data in a more systematic manner would
help inform future treatment decisions. Vaccines and antiviral
agents are currently unavailable for enterovirus D68, although
enterovirus A71 vaccines are being trialled.20
Surveillance and genotyping of enteroviruses must be enhanced
and prioritised globally in order to track spread, allow evaluation
of novel therapies and vaccines, and reduce outbreaks of acute
flaccid myelitis. Techniques such as next generation enteroviral
sequencing provide information on specific genome mutations
associated with virulence and should inform vaccine design to
reduce this serious threat.
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